CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
Medical and recreational cannabis – a global overview
Check out our new regulatory data on medical and recreational cannabis in 54 jurisdictions around the world
The report, accompanied by a more detailed database, provides an overview of the regulatory situation in the selected countries, using maps, and assesses the likelihood that the status quo may change in the future.